PCN14 A Pharmacoeconomic Appraisal of Cabazitaxel Versus Abiraterone for the Second-Line Treatment of Patients with Metastatic Hormone-Refractory Prostate Cancer (MHRPC) Progressing After the Treatment with Docetaxel: a Systematic Review

Thumbnail Image

Date

2014-05-01

Authors

Bektur, C.
Nurgozhin, T.

Journal Title

Journal ISSN

Volume Title

Publisher

Abstract

Description

Keywords

Citation

URI

https://www.sciencedirect.com/science/article/pii/S1098301514004604
 http://nur.nu.edu.kz/handle/123456789/2871

Collections

Articles

Endorsement

Review

Supplemented By

Referenced By